IL162816A0 - Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera - Google Patents
Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the visceraInfo
- Publication number
- IL162816A0 IL162816A0 IL16281603A IL16281603A IL162816A0 IL 162816 A0 IL162816 A0 IL 162816A0 IL 16281603 A IL16281603 A IL 16281603A IL 16281603 A IL16281603 A IL 16281603A IL 162816 A0 IL162816 A0 IL 162816A0
- Authority
- IL
- Israel
- Prior art keywords
- acylaminoalkenylene
- viscera
- amide derivatives
- motility disorders
- functional motility
- Prior art date
Links
- 230000004899 motility Effects 0.000 title 1
- 210000001835 viscera Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0203061.7A GB0203061D0 (en) | 2002-02-08 | 2002-02-08 | Organic compounds |
| PCT/EP2003/001227 WO2003066062A1 (en) | 2002-02-08 | 2003-02-07 | Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL162816A0 true IL162816A0 (en) | 2005-11-20 |
Family
ID=9930743
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16281603A IL162816A0 (en) | 2002-02-08 | 2003-02-07 | Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera |
| IL162816A IL162816A (en) | 2002-02-08 | 2004-07-01 | Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL162816A IL162816A (en) | 2002-02-08 | 2004-07-01 | Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20050203164A1 (https=) |
| EP (2) | EP1476167A1 (https=) |
| JP (2) | JP2005516994A (https=) |
| KR (2) | KR20100100994A (https=) |
| CN (1) | CN1301714C (https=) |
| AU (1) | AU2003244446B2 (https=) |
| BR (1) | BR0307479A (https=) |
| CA (1) | CA2471964A1 (https=) |
| GB (1) | GB0203061D0 (https=) |
| IL (2) | IL162816A0 (https=) |
| MX (1) | MXPA04007640A (https=) |
| NO (1) | NO20043735L (https=) |
| NZ (1) | NZ534231A (https=) |
| PL (1) | PL370255A1 (https=) |
| RU (1) | RU2353356C2 (https=) |
| TW (1) | TWI330177B (https=) |
| WO (1) | WO2003066062A1 (https=) |
| ZA (1) | ZA200404960B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0203061D0 (en) * | 2002-02-08 | 2002-03-27 | Novartis Ag | Organic compounds |
| EP1686985A2 (en) | 2003-10-27 | 2006-08-09 | Novartis AG | Use of neurokinin antagonists in the treatment of urinary incontinence |
| CN101568331A (zh) | 2006-09-08 | 2009-10-28 | 奥尔制药有限公司 | 减少或缓解消化道炎症的方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5217996A (en) * | 1992-01-22 | 1993-06-08 | Ciba-Geigy Corporation | Biaryl substituted 4-amino-butyric acid amides |
| US5457101A (en) * | 1994-06-03 | 1995-10-10 | Eli Lilly And Company | Thieno[1,5]benzoidiazepine use |
| MX9706394A (es) * | 1995-02-22 | 1997-11-29 | Novartis Ag | Compuestos de 1-aril-2-acilamino-etano y su uso como antagonistas de neuroquinina, especialmente neuroquinina-1. |
| CR5278A (es) * | 1995-03-24 | 1996-07-04 | Lilly Co Eli | Formulacion oral de 2-metil-tieno-benzodiacepina |
| GB9525296D0 (en) * | 1995-12-11 | 1996-02-07 | Merck Sharp & Dohme | Therapeutic agents |
| MY132550A (en) * | 1996-08-22 | 2007-10-31 | Novartis Ag | Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists |
| GB9708484D0 (en) * | 1997-04-25 | 1997-06-18 | Merck Sharp & Dohme | Therapeutic agents |
| PL191496B1 (pl) * | 1997-07-02 | 2006-05-31 | Merck & Co Inc | Odmiana polimorficzna 2-(R)-{1-(R) -[3,5-bis(trifluorometylo)-fenylo]etoksy} -3-(S)-(4-fluoro) fenylo-4-[3-(5-okso-1H,4H-1,2,4-triazolo)metylo] morfoliny, sposób jej wytwarzania, zawierająca ją kompozycja farmaceutyczna i jej zastosowanie |
| TW520370B (en) * | 1998-11-20 | 2003-02-11 | Meiji Seika Kaisha | Benzooxazole derivatives and a pharmaceutical composition containing the derivatives as an active ingredient |
| RU2161894C1 (ru) * | 1999-08-10 | 2001-01-20 | НИФ "Ультрасан" | Лечебно-профилактическая композиция |
| GB0010958D0 (en) | 2000-05-05 | 2000-06-28 | Novartis Ag | Organic compounds |
| US20040058914A1 (en) * | 2000-12-22 | 2004-03-25 | Takayuki Doi | Combination drugs |
| GB0203061D0 (en) * | 2002-02-08 | 2002-03-27 | Novartis Ag | Organic compounds |
-
2002
- 2002-02-08 GB GBGB0203061.7A patent/GB0203061D0/en not_active Ceased
-
2003
- 2003-02-07 AU AU2003244446A patent/AU2003244446B2/en not_active Ceased
- 2003-02-07 IL IL16281603A patent/IL162816A0/xx unknown
- 2003-02-07 BR BR0307479-0A patent/BR0307479A/pt not_active IP Right Cessation
- 2003-02-07 NZ NZ534231A patent/NZ534231A/en not_active IP Right Cessation
- 2003-02-07 US US10/501,496 patent/US20050203164A1/en not_active Abandoned
- 2003-02-07 TW TW092102519A patent/TWI330177B/zh not_active IP Right Cessation
- 2003-02-07 PL PL03370255A patent/PL370255A1/xx not_active Application Discontinuation
- 2003-02-07 KR KR1020107017008A patent/KR20100100994A/ko not_active Ceased
- 2003-02-07 RU RU2004127132/15A patent/RU2353356C2/ru not_active IP Right Cessation
- 2003-02-07 EP EP03737323A patent/EP1476167A1/en not_active Ceased
- 2003-02-07 CA CA002471964A patent/CA2471964A1/en not_active Abandoned
- 2003-02-07 EP EP10163570A patent/EP2216025A3/en not_active Withdrawn
- 2003-02-07 KR KR10-2004-7012191A patent/KR20040081492A/ko not_active Ceased
- 2003-02-07 JP JP2003565486A patent/JP2005516994A/ja not_active Ceased
- 2003-02-07 WO PCT/EP2003/001227 patent/WO2003066062A1/en not_active Ceased
- 2003-02-07 CN CNB038034859A patent/CN1301714C/zh not_active Expired - Fee Related
- 2003-02-07 MX MXPA04007640A patent/MXPA04007640A/es active IP Right Grant
-
2004
- 2004-06-23 ZA ZA200404960A patent/ZA200404960B/en unknown
- 2004-07-01 IL IL162816A patent/IL162816A/en not_active IP Right Cessation
- 2004-09-07 NO NO20043735A patent/NO20043735L/no not_active Application Discontinuation
-
2007
- 2007-08-23 US US11/895,226 patent/US20070293473A1/en not_active Abandoned
-
2010
- 2010-07-22 JP JP2010164587A patent/JP2010241835A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20040081492A (ko) | 2004-09-21 |
| US20070293473A1 (en) | 2007-12-20 |
| GB0203061D0 (en) | 2002-03-27 |
| EP2216025A3 (en) | 2010-11-10 |
| JP2005516994A (ja) | 2005-06-09 |
| EP2216025A2 (en) | 2010-08-11 |
| KR20100100994A (ko) | 2010-09-15 |
| ZA200404960B (en) | 2006-05-31 |
| TWI330177B (en) | 2010-09-11 |
| NO20043735L (no) | 2004-09-07 |
| PL370255A1 (en) | 2005-05-16 |
| EP1476167A1 (en) | 2004-11-17 |
| MXPA04007640A (es) | 2004-11-10 |
| JP2010241835A (ja) | 2010-10-28 |
| IL162816A (en) | 2010-11-30 |
| RU2004127132A (ru) | 2005-06-10 |
| US20050203164A1 (en) | 2005-09-15 |
| RU2353356C2 (ru) | 2009-04-27 |
| WO2003066062A1 (en) | 2003-08-14 |
| AU2003244446A1 (en) | 2003-09-02 |
| TW200302818A (en) | 2003-08-16 |
| AU2003244446B2 (en) | 2006-08-10 |
| CA2471964A1 (en) | 2003-08-14 |
| CN1301714C (zh) | 2007-02-28 |
| HK1077749A1 (en) | 2006-02-24 |
| BR0307479A (pt) | 2004-12-07 |
| NZ534231A (en) | 2007-02-23 |
| CN1627947A (zh) | 2005-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2004003110A0 (en) | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials | |
| AP1850A (en) | Spiroindolineplperidine derivatives | |
| EG24050A (en) | Heterocylocarboxamide derivatives | |
| IL189657A0 (en) | N-phenyl-2-pyrimidine-amine derivatives | |
| IL166121A0 (en) | Indole-3-sulphur derivatives | |
| EP1522540A4 (en) | AZAARENE DERIVATIVES | |
| ZA200410409B (en) | Use of thio-oxindole derivatives in treatment of hormonerelated conditions | |
| ZA200500471B (en) | N-biarylmethyl aminocycloalkanecarboxamide derivatives | |
| IL163868A0 (en) | Hermiasterlin derivatives and uses thereof | |
| AU2003222659A8 (en) | 23-o-substituted 5-o-mycaminosyltylonide derivatives | |
| AU2003297612A8 (en) | 2-substituted-3-propenamide derivatives and methods of using the same | |
| GB0423856D0 (en) | Amide derivatives | |
| AU2003205963A8 (en) | Azaphenylalanine derivatives and their use as antithrombotic agents | |
| IL162816A (en) | Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera | |
| GB0316910D0 (en) | Fluorocombretastatin and derivatives thereof | |
| AU2003235889A8 (en) | Amide derivatives | |
| EP1531854A4 (en) | O-DERIVATED NOCATHIACIN DERIVATIVES | |
| GB0307231D0 (en) | 7-Nitroindoline derivatives and their uses | |
| GB0221270D0 (en) | Moke 2 | |
| AU2003243397A8 (en) | Homo-camptothecin derivatives | |
| EP1499338A4 (en) | 7-HYDROXY-16ALPHA-FLUORO-5-ANDROSENES-17-ONE AND 7-HYDROXY-16ALPHA-FLUORO-5-ANDROSTAN-17-ONE AND THEIR DERIVATIVES | |
| ZA200500735B (en) | Novel quinuclidine derivatives and their use | |
| GB0208846D0 (en) | The moke | |
| GB0209685D0 (en) | Towel | |
| GB0221287D0 (en) | The shower back scratcher |